Your donations are making a difference in skin cancer research
Because of your support, Michigan State University College of Human Medicine researchers are breaking ground in skin cancer research.
Dr. Richard Neubig and his research team have discovered a promising new drug that stops the spread of melanoma by 90 percent.
Dr. Richard Neubig
Melanoma, the most dangerous form of skin cancer, can spread quickly and aggressively throughout the body, attacking distant organs such as the brain and lungs. Dr. Neubig’s research could be highly effective in battling the disease’s ability to spread. If the disease is caught early, chance of death is only 2 percent. If caught late, that figure rises to 84 percent.
Melanoma cells from Dr. Neubig’s lab
Dr. Neubig’s research is supported in part by MSU Gran Fondo donations and grants from the National Institutes of Health. Additional researchers from MSU and the University of Michigan contributed to the project. Learn more about the research.
Help us continue the fight against skin cancer by riding the MSU Gran Fondo on June 24, volunteering or donating to the cause.
Dr. Benaderet won a TREK bike as a top fundraiser in 2014.
As a cardiologist, David Benaderet, MD, always urges his patients to get plenty of exercise. He takes his own advice.
“I’m an avid cyclist,” he said. “It adds a little credibility to my recommendation if I’m involved. It’s also for my wellbeing, physical and mental.”
And it is one way Benaderet, as a 1980 graduate of the Michigan State University College of Human Medicine, can give something back to his alma mater.
He has ridden the 80-mile loop, the longest route, in all four of the MSU Gran Fondos, and this year he donated $2,050, making him one of the top fundraisers for the college’s skin cancer research program.
Benaderet, whose office is in Sterling Heights, has encouraged colleagues and fellow alumnae to join the ride.
“I think it’s important for the graduates of the medical school to embrace it,” he said, adding that it’s a way of showing “appreciation for the medical school.”